설폰아미드 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.8%의 성장률로 37억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 병용요법에 대한 수요 증가, 항균제 내성 관리에 대한 관심 증가, 개발도상국의 의료 접근성 확대, 농업 및 축산업 분야에서의 사용 확대, 설폰아미드 제제에 대한 규제 당국의 지지적 승인 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 약물 전달 기술의 발전, 설폰아미드 유도체의 혁신, 표적 항균 요법의 개발, 항균제의 지속적인 연구개발, 신약 개발에 인공지능의 통합 등을 들 수 있습니다.
피부 감염의 확산은 설폰아미드 시장의 성장을 견인할 것으로 예측됩니다. 피부 감염은 피부에 침입한 세균, 바이러스, 진균, 곰팡이, 기생충에 의해 발생하며 발적, 부종, 통증, 가려움증, 화농 등의 증상을 유발합니다. 피부 감염증 증가는 항생제 내성균 증가에 기인하는 바가 크며, 일반적인 감염은 치료가 어렵고 확산되기 쉽습니다. 설폰아미드는 박테리아의 증식을 억제하고 엽산의 합성을 억제하여 다양한 감수성 박테리아에 효과적이며, 피부 감염 치료에 효과적입니다. 예를 들어, 2025년 2월 미국 비영리단체인 미국피부과학회는 매년 약 5,000만 명의 미국인이 여드름을 앓고 있으며, 이는 미국에서 가장 흔한 피부 질환이라고 보고했습니다. 그 결과, 피부 감염의 유병률 증가는 설폰아미드 시장의 성장에 박차를 가하고 있습니다.
설폰아미드 시장의 기업들은 설폰아미드 기반 약물의 치료 용도를 확장하고, 희귀 신경근 질환의 미충족 수요를 충족시키기 위해 원발성 주기성 마비(PPP)와 같은 혁신적인 치료법을 개발하는 데 주력하고 있습니다. 근육 약화 및 마비 에피소드를 유발하는 희귀 유전성 신경근육 질환군을 관리하기 위한 것입니다. 예를 들어, 2024년 5월 영국에 본사를 둔 제약사 사이클 파마슈티컬스(Cycle Pharmaceuticals Limited)는 저칼륨혈증성 주기성 마비(HypoPP), 고칼륨혈증성 주기성 마비(HyperPP) 및 유사 질환 환자를 위한 치료 옵션으로 ORMALVITM(디클로르페나미드)을 발표했습니다. 디클로르페나미드)를 발표했습니다. FDA 승인을 받은 이 치료제는 칼륨 농도 변동과 관련된 근육 약화 및 마비를 특징으로 하는 이 유전성 질환에 특화된 치료제를 제공합니다. 이번 출시에서 주목할 만한 점은 환자 중심의 접근 방식과 맞춤형 지원 서비스를 통해 접근성과 순응도를 향상시키는 데 중점을 두고 있다는 점입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 술폰아미드 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 술폰아미드 시장 : 성장률 분석
- 세계의 술폰아미드 시장 실적 : 규모와 성장, 2019-2024
- 세계의 술폰아미드 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 술폰아미드 전체 시장(TAM)
제6장 시장 세분화
- 세계의 술폰아미드 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 경구 술폰아미드
- 국소용 술폰아미드
- 주사용 술폰아미드
- 세계의 술폰아미드 시장 : 화학 구조별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Sulfanilamide
- Sulfacetamide
- Sulfamethoxazole
- 세계의 술폰아미드 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 항균
- 항진균제
- 항바이러스제
- 이뇨제
- 항당뇨병제
- 기타 용도
- 세계의 술폰아미드 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 클리닉
- 연구실
- 기타 최종사용자
- 세계의 술폰아미드 시장 : 경구 술폰아미드 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Sulfamethoxazole
- Sulfisoxazole
- Sulfadiazine
- Sulfalene
- 세계의 술폰아미드 시장 : 국소 술폰아미드 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Sulfacetamide Sodium
- Silver Sulfadiazine
- Sulfamylon
- Sulfadiazine Cream
- 세계의 술폰아미드 시장 : 주사용 술폰아미드 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Sulfamethoxazole
- Sulfadiazine Sodium
- Sulfamethoxypyridazine
제7장 지역별/국가별 분석
- 세계의 술폰아미드 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 술폰아미드 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 술폰아미드 시장 : 경쟁 구도
- 술폰아미드 시장 : 기업 개요
- Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
- Intas Pharmaceuticals Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
- Cadila Pharmaceuticals Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Amneal Pharmaceuticals LLC
- Lupin Limited
- Bimeda Holdings PLC
- Fera Science Limited
- Virchow Laboratories Limited
- Hebei Veyong Bio-Chemical Co. Ltd.
- Interchemie Werken De Adelaar B.V.
- AdvaCare Pharma
- Manus Aktteva Biopharma LLP
- Suleshvari Pharma
- Shree Vardayini Chemical Industries Private Limited
- VetOne
- Zydus Cadila Healthcare Limited
- Mission Pharmacal Company
- Allegis Pharmaceuticals LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 술폰아미드 시장(2029년) : 새로운 기회를 제공하는 국가
- 술폰아미드 시장(2029년) : 새로운 기회를 제공하는 부문
- 술폰아미드 시장(2029년) : 성장 전략
제36장 부록
LSH
Sulfonamide refers to a group of synthetic antimicrobial agents containing the sulfonamide group, used to treat bacterial infections by inhibiting folic acid synthesis in microbes. These compounds were among the earliest antibiotics developed and remain in use today as part of combination therapies for various infections.
The main product types of sulfonamide include oral sulfonamides, topical sulfonamides, and injectable sulfonamides. Oral sulfonamides are antibiotics that contain the sulfonamide group (-SO2NH2) in their chemical structure. The key chemical structures include sulfanilamide, sulfacetamide, and sulfamethoxazole. Applications include antibacterial, antifungal, antiviral, diuretics, antidiabetic, and others, and they are used by various end users such as hospitals, clinics, research laboratories, and others.
The sulfonamide market research report is one of a series of new reports from The Business Research Company that provides sulfonamide market statistics, including the sulfonamide industry global market size, regional shares, competitors with the sulfonamide market share, detailed sulfonamide market segments, market trends, and opportunities, and any further data you may need to thrive in the sulfonamide industry. This sulfonamide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sulfonamide market size has grown strongly in recent years. It will grow from $2.72 billion in 2024 to $2.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing prevalence of bacterial infections, growing availability of generic sulfonamide drugs, rising cost-effective treatment options, expanded use in veterinary medicine, and the expanding pharmaceutical manufacturing capacity.
The sulfonamide market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for combination therapies, increasing focus on antimicrobial resistance management, expansion of healthcare access in developing regions, growing applications in agriculture and animal husbandry, and supportive regulatory approvals for sulfonamide formulations. Major trends in the forecast period include advancements in drug delivery technologies, innovations in sulfonamide derivatives, development of targeted antibacterial therapies, ongoing research and development in antimicrobial agents, and integration of artificial intelligence in drug discovery.
The growing prevalence of skin infections is expected to drive the expansion of the sulfonamide market. Skin infections, caused by bacteria, viruses, fungi, or parasites invading the skin, lead to symptoms such as redness, swelling, pain, itching, or pus formation. The rise in skin infections is largely due to the increasing presence of antibiotic-resistant bacteria, making common infections more difficult to treat and more likely to spread. Sulfonamides are effective in treating skin infections by inhibiting bacterial growth and disrupting folic acid synthesis, making them effective against various susceptible bacteria. For example, in February 2025, the American Academy of Dermatology, a U.S.-based nonprofit organization, reported that approximately 50 million Americans suffer from acne each year, making it the most common skin condition in the country. As a result, the increasing prevalence of skin infections is fueling the growth of the sulfonamide market.
Companies in the sulfonamide market are focusing on developing innovative therapies, such as those for primary periodic paralysis (PPP), to expand the therapeutic applications of sulfonamide-based drugs and address unmet needs in rare neuromuscular disorders. PPP therapies are designed to manage a group of rare, inherited neuromuscular disorders that cause episodes of muscle weakness or paralysis triggered by changes in blood potassium levels. For example, in May 2024, Cycle Pharmaceuticals Limited, a U.K.-based pharmaceutical company, introduced ORMALVITM (dichlorphenamide) as a therapy option for patients with hypokalemic periodic paralysis (HypoPP), hyperkalemic periodic paralysis (HyperPP), and similar conditions. This FDA-approved therapy provides a specialized treatment for these genetic disorders, characterized by muscle weakness or paralysis linked to fluctuations in potassium levels. A notable feature of this launch is Cycle's patient-centric approach, which focuses on improving accessibility and adherence through tailored support services.
In June 2023, Shionogi & Company Limited, a Japan-based pharmaceutical company, merged with Qpex Biopharma Inc. to accelerate antibiotic research and development, addressing the growing issue of antimicrobial resistance (AMR). This merger allows Shionogi to enhance its expertise in antibiotic research and AMR by combining its strengths with Qpex Biopharma's innovative compounds and networks, speeding up the development of vital pharmaceuticals. Qpex Biopharma Inc. is a U.S.-based company focused on creating novel anti-infective therapies, particularly those targeting drug-resistant infections.
Major players in the sulfonamide market are Abbott Laboratories, Novartis AG, Teva Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Lupin Limited, Bimeda Holdings PLC, Fera Science Limited, Virchow Laboratories Limited, Hebei Veyong Bio-Chemical Co. Ltd., Interchemie Werken De Adelaar B.V., AdvaCare Pharma, Manus Aktteva Biopharma LLP, Suleshvari Pharma, Shree Vardayini Chemical Industries Private Limited, VetOne, Zydus Cadila Healthcare Limited, Mission Pharmacal Company, Allegis Pharmaceuticals LLC.
North America was the largest region in the sulfonamide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sulfonamide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sulfonamide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sulfonamide market consists of sales of sulfamethoxazole, sulfadiazine, furosemide, and thiazide diuretics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sulfonamide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sulfonamide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sulfonamide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sulfonamide market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Oral Sulfonamides; Topical Sulfonamides; Injectable Sulfonamides
- 2) By Chemical Structure: Sulfanilamide; Sulfacetamide; Sulfamethoxazole
- 3) By Application: Antibacterial; Antifungal; Antiviral; Diuretics; Antidiabetic; Other Applications
- 4) By End-User: Hospitals; Clinics; Research Laboratories; Other End Users
- Subsegments:
- 1) By Oral Sulfonamides: Sulfamethoxazole; Sulfisoxazole; Sulfadiazine; Sulfalene
- 2) By Topical Sulfonamides: Sulfacetamide Sodium; Silver Sulfadiazine; Sulfamylon; Sulfadiazine Cream
- 3) By Injectable Sulfonamides: Sulfamethoxazole; Sulfadiazine Sodium; Sulfamethoxypyridazine
- Companies Mentioned: Abbott Laboratories; Novartis AG; Teva Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited; Cadila Pharmaceuticals Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sulfonamide Market Characteristics
3. Sulfonamide Market Trends And Strategies
4. Sulfonamide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sulfonamide Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sulfonamide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sulfonamide Market Growth Rate Analysis
- 5.4. Global Sulfonamide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sulfonamide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sulfonamide Total Addressable Market (TAM)
6. Sulfonamide Market Segmentation
- 6.1. Global Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Sulfonamides
- Topical Sulfonamides
- Injectable Sulfonamides
- 6.2. Global Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfanilamide
- Sulfacetamide
- Sulfamethoxazole
- 6.3. Global Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antibacterial
- Antifungal
- Antiviral
- Diuretics
- Antidiabetic
- Other Applications
- 6.4. Global Sulfonamide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Research Laboratories
- Other End Users
- 6.5. Global Sulfonamide Market, Sub-Segmentation Of Oral Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfamethoxazole
- Sulfisoxazole
- Sulfadiazine
- Sulfalene
- 6.6. Global Sulfonamide Market, Sub-Segmentation Of Topical Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfacetamide Sodium
- Silver Sulfadiazine
- Sulfamylon
- Sulfadiazine Cream
- 6.7. Global Sulfonamide Market, Sub-Segmentation Of Injectable Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfamethoxazole
- Sulfadiazine Sodium
- Sulfamethoxypyridazine
7. Sulfonamide Market Regional And Country Analysis
- 7.1. Global Sulfonamide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sulfonamide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sulfonamide Market
- 8.1. Asia-Pacific Sulfonamide Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sulfonamide Market
- 9.1. China Sulfonamide Market Overview
- 9.2. China Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sulfonamide Market
- 10.1. India Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sulfonamide Market
- 11.1. Japan Sulfonamide Market Overview
- 11.2. Japan Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sulfonamide Market
- 12.1. Australia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sulfonamide Market
- 13.1. Indonesia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sulfonamide Market
- 14.1. South Korea Sulfonamide Market Overview
- 14.2. South Korea Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sulfonamide Market
- 15.1. Western Europe Sulfonamide Market Overview
- 15.2. Western Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sulfonamide Market
- 16.1. UK Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sulfonamide Market
- 17.1. Germany Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sulfonamide Market
- 18.1. France Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sulfonamide Market
- 19.1. Italy Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sulfonamide Market
- 20.1. Spain Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sulfonamide Market
- 21.1. Eastern Europe Sulfonamide Market Overview
- 21.2. Eastern Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sulfonamide Market
- 22.1. Russia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sulfonamide Market
- 23.1. North America Sulfonamide Market Overview
- 23.2. North America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sulfonamide Market
- 24.1. USA Sulfonamide Market Overview
- 24.2. USA Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sulfonamide Market
- 25.1. Canada Sulfonamide Market Overview
- 25.2. Canada Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sulfonamide Market
- 26.1. South America Sulfonamide Market Overview
- 26.2. South America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sulfonamide Market
- 27.1. Brazil Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sulfonamide Market
- 28.1. Middle East Sulfonamide Market Overview
- 28.2. Middle East Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sulfonamide Market
- 29.1. Africa Sulfonamide Market Overview
- 29.2. Africa Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sulfonamide Market Competitive Landscape And Company Profiles
- 30.1. Sulfonamide Market Competitive Landscape
- 30.2. Sulfonamide Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
31. Sulfonamide Market Other Major And Innovative Companies
- 31.1. Amneal Pharmaceuticals LLC
- 31.2. Lupin Limited
- 31.3. Bimeda Holdings PLC
- 31.4. Fera Science Limited
- 31.5. Virchow Laboratories Limited
- 31.6. Hebei Veyong Bio-Chemical Co. Ltd.
- 31.7. Interchemie Werken De Adelaar B.V.
- 31.8. AdvaCare Pharma
- 31.9. Manus Aktteva Biopharma LLP
- 31.10. Suleshvari Pharma
- 31.11. Shree Vardayini Chemical Industries Private Limited
- 31.12. VetOne
- 31.13. Zydus Cadila Healthcare Limited
- 31.14. Mission Pharmacal Company
- 31.15. Allegis Pharmaceuticals LLC
32. Global Sulfonamide Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sulfonamide Market
34. Recent Developments In The Sulfonamide Market
35. Sulfonamide Market High Potential Countries, Segments and Strategies
- 35.1 Sulfonamide Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sulfonamide Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sulfonamide Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
